4//SEC Filing
ALNYLAM PHARMACEUTICALS, INC. 4
Accession 0001553878-14-000028
$ALNYCIK 0001178670operating
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:20 PM ET
Size
5.6 KB
Accession
0001553878-14-000028
Insider Transaction Report
Form 4
Reid Laurence
SVP, Chief Business Officer
Transactions
- Award
Performance Based Stock Option (right to buy)
2014-12-12+6,667→ 6,667 totalExercise: $63.00From: 2014-12-12Exp: 2023-12-18→ Common Stock (6,667 underlying)
Footnotes (1)
- [F1]On December 18, 2013, the reporting person was granted a performance based stock option to purchase shares of ALNY Common Stock. One-third of the shares subject to the option will vest upon the achievement of each of three specific clinical development and regulatory events, as approved by our compensation committee. Effective December 12, 2014, the compensation committee of the Company determined the first performance criteria had been met and the option will vest as to one-third of the shares.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeoperating
Related Parties
1- filerCIK 0001178670
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:20 PM ET
- Size
- 5.6 KB